Foamix Ltd. (Ness Ziona, Israel) announced it has received two separate patents for its OilGel technology. Patent No. 6,994,863 was issued Feb. 7, 2006, by the U.S. Patent and Trademark Office (USPTO). The patent, titled "Pharmaceutical and Cosmetic Carrier or Composition for Topical Application" covers the company's methods of treatment of various disorders using the technology.
The second patent, number 782515, was concurrently issued by the Australian patent office. The patent covers composition and the use of the technology as a treatment for dermatological and ophthalmic diseases. The term of the Australian patent is through Jan. 10, 2021. The patented technology is a delivery system of medicated actives for the treatment of skin and eye diseases that transforms a semi-solid into a liquid after application without creating a sticky feeling or blurred vision.
“We are excited to have received the latest in a series of U.S. patents for this technology. We are equally thrilled to have opened the door in Australia. This is indicative of Foamix’s ongoing effort to develop its technology for use worldwide,” said Dov Tamarkin, Ph.D., Foamix, in a press statement.